IRIX लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (2 May 2024 @ 01:30):

Stats
आज की मात्रा	5 345.00
औसत मात्रा	36 334.00
बाजार मूल्य	45.83M
EPS	$0 ( 2024-03-26 )
अगली कमाई की तारीख	( $-0.120 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.78
ATR14	$0.0310 (1.10%)

Insider Trading

Date	Person	Action	Amount	type
2023-09-19	Mercer Patrick	Buy	115 000	Stock Option (Right to buy)
2023-06-14	Shuda Scott	Buy	39 267	Common Stock
2023-06-14	Ludlum Ken	Buy	39 267	Common Stock
2023-06-14	Grove Robert Earle	Buy	39 267	Common Stock
2023-06-14	Huss Beverly A	Buy	39 267	Common Stock

INSIDER POWER
98.56
Last 95 transactions
Buy: 1 370 143 \| Sell: 45 959

मात्रा सहसंबंध

लंबा: -0.06 (neutral)

छोटा: 0.15 (neutral)

Signal:(46.186) Neutral

IRIDEX Corp सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
APOP	0.953
RMRM	0.927
GAINL	0.885
CMLF	0.847
ISNS	0.835
FEYE	0.832
SPRT	0.823
TLGT	0.823
PAIC	0.818
SVAC	0.817

10 सबसे अधिक नकारात्मक सहसंबंध
MMAC	-0.909
BOCH	-0.904
NETE	-0.852
DSPG	-0.843
AMRB	-0.83

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

IRIDEX Corp सहसंबंध - मुद्रा/वस्त्र

-0.29
( neutral )

-0.35
( neutral )

-0.32
( neutral )

-0.14
( neutral )

0.00
( neutral )

0.03
( neutral )

IRIDEX Corp वित्तीय

Annual	2023
राजस्व:	$51.87M
सकल लाभ:	$21.47M (41.40 %)
EPS:	$-0.590

FY	2023
राजस्व:	$51.87M
सकल लाभ:	$21.47M (41.40 %)
EPS:	$-0.590

FY	2022
राजस्व:	$56.97M
सकल लाभ:	$25.37M (44.53 %)
EPS:	$-0.470

FY	2021
राजस्व:	$53.90M
सकल लाभ:	$22.83M (42.36 %)
EPS:	$-0.340

Financial Reports:

No articles found.

IRIDEX Corp

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.